Evidence map›Paper›PMID 42311002›Full record

ArticleAdvanced healthcare materials2026

Xinmiao Lu, Yue Li, Hanyu Bai, Zhu Zhang, Xiaohui Wang, Yunjie Li, Hua Pang

Abstract read
In one paragraph

Article in Advanced healthcare materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xinmiao LuDepartment of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.ORCID https://orcid.org/0009-0007-1968-1976
Yue LiDepartment of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Hanyu BaiDepartment of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Zhu ZhangDepartment of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Xiaohui WangDepartment of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Yunjie LiDepartment of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Hua PangDepartment of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Funding

Chongqing Natural Science Foundation CSTB2025NSCQ-GPX1247National Natural Science Foundation of China 82472019
6 · The paper itself

Abstract

Molecular imaging is deeply involved in the

Indexed as

Embolization, TherapeuticMicrospheresYttrium RadioisotopesAnimalsBiotinCell Line, TumorGallium RadioisotopesHumansMicePolystyrenesPositron-Emission TomographyRadioembolization, TherapeuticRatsStreptavidinTissue DistributionBiotinGallium-68Gallium RadioisotopesPolystyrenesStreptavidinYttrium-90Yttrium Radioisotopes90Y‐SIRTbioorthogonal chemistryin situ labellingmolecular imaging

Identifiers

PMID42311002
PMCPMC13410845

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.